ArticleJournal of geriatric oncology2025
Racial disparities in longitudinal frailty state transitions among older cancer survivors.
Article in Journal of geriatric oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionBlack older patients with cancer are at high risk of frailty during cancer treatment, yet racial disparities in long-term frailty state transitions during the survivorship phase are understudied. MATERIALS AND
methodsWe conducted a longitudinal analysis of older cancer survivors (≥65 years) using rounds 1-9 (2011-2019) of the National Health and Aging Trends Study. A multistate Markov model assessed one-year transitions across Fried frailty phenotypes states (robust, prefrail, frail) and death, stratified by self-reported race (Black vs. non-Black).
resultsAmong 1303 survivors, 55 % were female, 24 % Black, and 76 % non-Black. Black survivors were less likely to remain robust (50 % vs. 57 %), more likely to stay frail (46 % vs. 39 %), more likely to die, and more likely to transition to poorer frailty states (e.g., robust to prefrail or frail) than non-Black survivors. DISCUSSION: Black older cancer survivors experience poorer frailty trajectories than non-Black counterparts, highlighting the need for targeted survivorship care to improve long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.